Clinical Trials Browser

Phase 2 × Nasopharyngeal Neoplasms × Zoledronic Acid × Clear all

NCT00697619 2012-03-07

To Evaluate the Efficacy of ZOMETA® in Treatment of Bone Metastases in Patients With Stage IV Nasopharyngeal Cancer

Phase 2 Completed

60 enrolled 8 charts

Nasopharyngeal Neoplasms